Hikma Pharmaceuticals PLC
LSE:HIK

Watchlist Manager
Hikma Pharmaceuticals PLC Logo
Hikma Pharmaceuticals PLC
LSE:HIK
Watchlist
Price: 1 794 GBX -0.83% Market Closed
Market Cap: 4B GBX
Have any thoughts about
Hikma Pharmaceuticals PLC?
Write Note

Hikma Pharmaceuticals PLC
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hikma Pharmaceuticals PLC
Tax Provision Peer Comparison

Comparables:
GSK
AZN
VRNA
INDV
DPH

Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Hikma Pharmaceuticals PLC
LSE:HIK
Tax Provision
-$77m
CAGR 3-Years
17%
CAGR 5-Years
-35%
CAGR 10-Years
2%
GlaxoSmithKline PLC
LSE:GSK
Tax Provision
-ÂŁ703m
CAGR 3-Years
-36%
CAGR 5-Years
-1%
CAGR 10-Years
2%
AstraZeneca PLC
LSE:AZN
Tax Provision
-$1.3B
CAGR 3-Years
-28%
CAGR 5-Years
-128%
CAGR 10-Years
-14%
Verona Pharma PLC
NASDAQ:VRNA
Tax Provision
-$2m
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Tax Provision
$50m
CAGR 3-Years
34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dechra Pharmaceuticals PLC
LSE:DPH
Tax Provision
ÂŁ8.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hikma Pharmaceuticals PLC's Tax Provision?
Tax Provision
-77m USD

Based on the financial report for Jun 30, 2024, Hikma Pharmaceuticals PLC's Tax Provision amounts to -77m USD.

What is Hikma Pharmaceuticals PLC's Tax Provision growth rate?
Tax Provision CAGR 10Y
2%

Over the last year, the Tax Provision growth was -7%. The average annual Tax Provision growth rates for Hikma Pharmaceuticals PLC have been 17% over the past three years , -35% over the past five years , and 2% over the past ten years .

Back to Top